Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) went up by 0.67% from its latest closing price compared to the recent 1-year high of $1.90. The company’s stock price has collected 6.34% of gains in the last five trading sessions. Press Release reported on 09/15/20 that Aerpio Announces Enrollment Completed in the 28-Day Phase 2 Razuprotafib Glaucoma Trial
Is It Worth Investing in Aerpio Pharmaceuticals Inc. (NASDAQ :ARPO) Right Now?
Opinions of the stock are interesting as 0 analysts out of 1 who provided ratings for Aerpio Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $2.00, which is $0.49 above the current price. ARPO currently public float of 34.44M and currently shorts hold a 2.32% ratio of that float. Today, the average trading volume of ARPO was 2.11M shares.
ARPO’s Market Performance
ARPO stocks went up by 6.34% for the week, with a monthly jump of 17.05% and a quarterly performance of 19.84%, while its annual performance rate touched 133.75%. The volatility ratio for the week stands at 9.98% while the volatility levels for the past 30 days are set at 12.18% for Aerpio Pharmaceuticals Inc.. The simple moving average for the period of the last 20 days is 10.97% for ARPO stocks with a simple moving average of 59.70% for the last 200 days.
Analysts’ Opinion of ARPO
Many brokerage firms have already submitted their reports for ARPO stocks, with Needham repeating the rating for ARPO by listing it as a “Buy.” The predicted price for ARPO in the upcoming period, according to Needham is $10 based on the research report published on July 23rd of the previous year 2018.
ARPO Trading at 5.70% from the 50-Day Moving Average
After a stumble in the market that brought ARPO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.53% of loss for the given period.
Volatility was left at 12.18%, however, over the last 30 days, the volatility rate increased by 9.98%, as shares surge +17.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.14% upper at present.
During the last 5 trading sessions, ARPO rose by +6.34%, which changed the moving average for the period of 200-days by +166.03% in comparison to the 20-day moving average, which settled at $1.3717. In addition, Aerpio Pharmaceuticals Inc. saw 142.18% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ARPO
The total capital return value is set at -47.35, while invested capital returns managed to touch -48.85. Equity return is now at value -9.70, with -9.00 for asset returns.
Based on Aerpio Pharmaceuticals Inc. (ARPO), the company’s capital structure generated 0.47 points at debt to equity in total, while total debt to capital is 0.46. Total debt to assets is 0.43, with long-term debt to equity ratio resting at 0.18. Finally, the long-term debt to capital ratio is 0.18.
The liquidity ratio also appears to be rather interesting for investors as it stands at 11.87.